Marcel G A, George C, Weill D, Catry E, Thao-Chan M
Ric Clin Lab. 1983;13 Suppl 3:71-81.
For Virchow vessel wall, coagulability and flow were the three eventual culprits of thrombogenesis. Pharmacological progress in the three fields has not been parallel. Strangely enough they have found possible therapy in the order of their description: first the vessel wall with vasodilators. Then 'coagulability' with anticoagulants, thrombolytics, antiaggregants. It is only more recently that new methods of investigation have allowed assessment and pharmacology of the main determinant of flow in microvessels: red cell deformability.
对于魏尔啸提出的血管壁、血液凝固性和血流这三个血栓形成的最终元凶而言,这三个领域的药理学进展并不平行。奇怪的是,他们按照所描述的顺序找到了可能的治疗方法:首先是使用血管扩张剂治疗血管壁问题。然后是使用抗凝剂、溶栓剂、抗聚集剂治疗“血液凝固性”问题。直到最近,新的研究方法才使得对微血管中血流的主要决定因素——红细胞变形性进行评估和开展药理学研究成为可能。